On August 18, 2025, Baxter International unveiled its new Hemopatch sealing hemostat, a room-temperature collagen pad tailored for use in both open and minimally invasive surgeries, following a decade-long collaboration with medical experts. This product’s development was driven by direct surgeon feedback, highlighting Baxter’s approach of addressing specific, real-world clinical needs through practical innovation. We’ll explore how delivering a new surgeon-informed hemostatic device could…